Try our mobile app

ИНН: 9704005675

E-disclosure page: 38507

Рост выручки hist 0.0%
Рост EBITDA hist 0.0%

Net Debt / Total Equity 0.0x
EBIT / Interest Payment 0.4x

млн руб
LTM Выручка 0
LTM EBITDA 0
LTM Операционная прибыль 3 801
LTM Чистая прибыль -3 099

Собственный капитал 24 211
Interest payment 8 561

Выручка и EBITDA

Квартальные значения (млн руб)

Изменения (г/г)

Денежный поток

FCF (млн руб) до искл. курс. разниц

Чистый долг / денежные средства (млн руб)

Облигации
Название ISIN Тип Доходность Валюта Цена Объем торгов (млн р.) Купон Ставка купона Премия Дата погашения/оферты Дюрация, лет
БинФарм1P2 RU000A104Z71 плав +23.6% RUB 100.0% 1.12 57.3 23.0% -0.4% 2025-10-21 0.0
БинФарм1P3 RU000A107E81 плав +22.7% RUB 98.4% 1.67 0.0 0.0% +2.2% 2026-12-14 1.2
БинФарм2P1 RU000A10CUB0 плав +21.7% RUB 99.6% 0.01 0.0 0.0% - 2027-06-18 1.7
БинФарм1P4 RU000A10AS28 фикс +20.5% RUB 105.0% 4.35 21.0 25.5% - 2026-08-05 0.8
БинФарм1P6 RU000A10BZT3 плав +19.3% RUB 102.0% 6.89 16.0 19.5% - 2027-01-13 1.3
БинФарм1P5 RU000A10B3Q2 фикс +18.1% RUB 105.8% 3.01 19.3 23.5% - 2026-09-16 0.9
БинФарм1P1 RU000A1043Z7 плав +16.9% RUB 100.8% 0.05 57.3 23.0% -1.1% 2025-11-24 0.1
MSFO data *The values are shown in mln RUB The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2025 q2 7 130-7%   117-87% -1 619>+200% 246>+200% -2 554+78%
2025 q1 7 130-7%   117-87% -1 619>+200% 246>+200% -2 554+78%
2024 q4 9 700+14%   1 783+81% 69>+200% 47+97% -1 726+88%
2024 q3 9 700+14%   1 783+81% 69>+200% 47+97% -1 726+88%
2024 q2 7 638+10%   873-20% -487<-100% 34+144% -1 435+101%
2024 q1 7 638+10%   873-20% -487<-100% 34+144% -1 435+90%
2023 q4 8 529+18%   984-19% 18-95% 24-26% -919+26%
2023 q3 8 529+18%   984-19% 18-95% 24-26% -919+26%
2023 q2 6 955+10%   1 094+8% 292-15% 14-59% -715+24%
2023 q1 6 955+10%   1 094+8% 253-26% 14-59% -754+31%
2022 q4 7 245+15%   1 219+22% 393-29% 32+119% -731+137%
2022 q3 7 245+15%   1 219+22% 393-29% 32+119% -731+137%
2022 q2 6 306+16%   1 010+38% 343-14% 34+142% -575+122%
2022 q1 6 306   1 010 343 34 -575
2021 q4 6 285>+200%   998>+200% 556>+200% 15+112% -309+31%
2021 q3 6 285   998 556 15 -309
2021 q2 5 423   732 399 14 -259
2020 q4 2 094   321<-100% 61<-100% 7 -235
2020 q3            
2019 q4     0 0    
2019 q3     0 0    


Balance


Implied interest rate for 2025 q2:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (2 554 - 246) * 4 / (31 964 - 496)

Q Total equity Total assets Net debt Implied interest rate NetDebt / LTM EBITDA
 
2025 q2 24 211-19% 73 337+3% 31 964+60% 29.3%  
2025 q1          
2024 q4 27 486-16% 74 107+3% 22 730+44% 30.2%  
2024 q3          
2024 q2 29 772-9% 70 981+10% 19 919+30% 28.8%  
2024 q1          
2023 q4 32 632+1% 72 065+14% 15 767-6% 23.4%  
2023 q3          
2023 q2 32 831-4% 64 742+2% 15 289-15% 18.9%  
2023 q1          
2022 q4 32 406-3% 63 067+15% 16 760+57% 17.2%  
2022 q3          
2022 q2 34 199 63 587 18 066 12.4%  
2022 q1          
2021 q4 33 446>+200% 54 883>+200% 10 650<-100% 11.7%  
2021 q3          
2021 q2          
2020 q4 0>+200% 0>+200% 0+73%    
2020 q3          
2019 q4 0 0 0    
2019 q3          


Cashflow


Q Operating cashflow Investing cashflow Financial cashflow
 
2025 q2 -3 183<-100% -1 170-1% 4 317>+200%
2025 q1 -3 183<-100% -1 170-1% 4 317>+200%
2024 q4 804-22% -1 046+8% 46-85%
2024 q3 804-22% -1 046+8% 46-85%
2024 q2 167-89% -1 187+79% 381<-100%
2024 q1 167-88% -1 187+90% 381<-100%
2023 q4 1 036+10% -971+21% 309<-100%
2023 q3 1 036+10% -971+21% 309<-100%
2023 q2 1 480<-100% -664-48% -944<-100%
2023 q1 1 442<-100% -626-51% -944<-100%
2022 q4 941+2% -800>+200% -240-23%
2022 q3 941+2% -800>+200% -240-23%
2022 q2 -2 254<-100% -1 286>+200% 3 240<-100%
2022 q1 -2 254 -1 286 3 240
2021 q4 921<-100% -225+23% -312+195%
2021 q3 921<-100% -225 -312
2021 q2 924 -71 -111
2020 q4 0>+200% -182 -106
2020 q3 0>+200%    
2019 q4 0    
2019 q3 0    
RSBU data *The values are shown in mln RUB The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2025 q2 9 747-21% 2 746-54% 44-76% -1 865+178% 397>+200% -1 984>+200%
2025 q1 5 553-46% 1 118-79% -1 093<-100% -2 234>+200% 300+126% -1 334>+200%
2024 q4 -33 609<-100%          
2024 q3 20 190+74% 12 852+106% 1 214+45% -115<-100% 136+33% -821>+200%
2024 q2 12 294+25% 5 960-5% 188-95% -670<-100% 113+27% -451+85%
2024 q1 10 283+7% 5 351+30% 171>+200% -654+111% 132+37% -436+63%
2023 q4 13 825+33% 7 362+40% 1 257-14% -305<-100% 101-6% -330+14%
2023 q3 11 589+21% 6 233+49% 838-21% 157-71% 102+24% -272+2%
2023 q2 9 841+24% 6 288+58% 3 482<-100% 4 057>+200% 89+44% -243+40%
2023 q1 9 612+12% 4 126+47% 53-95% -310<-100% 97+17% -267+157%
2022 q4 10 374>+200% 5 258>+200% 1 456<-100% 3 124<-100% 108>+200% -290>+200%
2022 q3 9 607>+200% 4 189>+200% 1 067<-100% 542-65% 82 -266
2022 q2 7 929>+200% 3 983<-100% -751>+200% 925<-100% 62 -174>+200%
2022 q1 8 601+100% 2 811 1 091<-100% 1 131<-100% 83 -104
2021 q4 140+100% 32 -624 -500>+200% 8 -8
2021 q3 13 12 -6 1 549    
2021 q2 1 -2 -3 -3   0
2021 q1 0   0 -814    
2020 q4 0     0    


Balance


Implied interest rate for 2025 q2:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (1 984 - 397) * 4 / (24 987 - 0)

Q Total equity Total assets Net debt
 
2025 q2 32 611-21% 86 334+8% 24 987+105%
2025 q1 34 476-22% 91 435+12% 23 964+174%
2024 q4     15 866+120%
2024 q3 38 347-15% 80 899+5% 17 002+70%
2024 q2 41 462-8% 79 727-6% 12 213+136%
2024 q1 44 132+8% 81 615+2% 8 755+65%
2023 q4 44 786+9% 81 205+7% 7 228+27%
2023 q3 45 091+11% 76 920+6% 9 974+135%
2023 q2 44 935+12% 84 851+26% 5 177+31%
2023 q1 40 877+5% 79 841+37% 5 314+184%
2022 q4 41 188+8% 75 781+82% 5 708<-100%
2022 q3 40 565+7% 72 564+74% 4 239
2022 q2 40 023+5% 67 252+61% 3 940
2022 q1 39 097+3% 58 079+39% 1 872
2021 q4 37 966>+200% 41 734>+200% -341>+200%
2021 q3 37 966 41 734  
2021 q2 37 966 41 734  
2021 q1 37 966 41 734  
2020 q4 0 0 0

Financial reports

RAS reports